Get started
RocketTickers

AnaptysBio Reports Positive Topline Data from Phase 2a

Long
AnaptysBio, Inc. (NASDAQ:ANAB)  
RocketTickers  
NASDAQ:ANAB   AnaptysBio, Inc.
Beyond Technical Analysis
2
0
beyondta
ANAB: AnaptysBio, Inc.
2018-09-24 06:30:00
AnaptysBio Reports Positive Topline Data from Phase 2a Proof-of-Concept Clinical Trial of Etokimab in Severe Eosinophilic Asthma
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.